Integrated DNA Technologies to Present on Rapid and Reliable Method of Gene Cloning at Antibody Engineering and Therapeutics

Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, will be speaking at the upcoming Antibody Engineering and Therapeutics conference in Huntington Beach, CA, December 9-12. Michel Cannieux, PhD, MBA, Director of Product Commercialization, Synthetic Biology at IDT will discuss a novel, rapid and reliable method to build and clone genes of interest at a fraction of the cost of full gene synthesis.

The talk, entitled “Rapid and Reliable Gene Construction with gBlocks™ Gene Fragments and Gibson Assembly™ Method” will take place at 12.00 on December 11. As double stranded, sequence verified DNA blocks up to 750 base pairs, gBlocks Gene Fragments have high sequence fidelity. As a result, they are ideal for use in a broad range of biological applications. This presentation will review the assembly of gene fragments using the Gibson Assembly Method and discuss design, protocols and applications.

Michel Cannieux holds a PhD in Plant Molecular Biology and has over 15 years’ experience in the life science industry, developing and supporting tools and solutions for functional analysis, including RNAi and synthetic biology.